_id

691723f53c536f8df2316a0c

Ticker

TTRX

Name

Turn Therapeutics Inc. Common Stock

Exchange

NASDAQ

Address

250 N Westlake Blvd, Westlake Village, CA, United States, 91362

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.turntherapeutics.com

Description

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Last Close

4.8

Volume

42457

Current Price

4.6896

Change

-0.24

Last Updated

2026-01-07T13:37:42.731Z

Image

https://logo.clearbit.com/www.turntherapeutics.com

Ipo Date

2025-10-08T00:00:00.000Z

Market Cap

-

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.994

Sentiment Sources

1

Rating

4

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-06-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

1366524

Operating Income

-1366524

Interest Expense

-

Pretax Income

-1240415

Net Income

-1240415

Eps

-0.05

Dividends Per Share

-

Shares Outstanding

0

Income Tax Expense

-

EBITDA

-1366524

Operating Margin

-

Total Other Income Expense Net

126109

Cash

3189943

Short Term Investments

-

Receivables

-

Inventories

-

Total Current Assets

3393961

Property Plant Equipment

99989

Total Assets

4331302

Payables

-

Short Term Debt

43405

Long Term Debt

-

Total Liabilities

2556806

Equity

1774496

Bs_currency_symbol

USD

Depreciation

-

Change In Working Capital

-

Cash From Operations

-

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

-

Net Change In Cash

-

Cf_currency_symbol

USD

PE

-

PB

65.5628435792473

ROE

-69.90238355003336

ROA

-28.638386332793235

FCF

-

Fcf Percent

-

Piotroski FScore

0

Health Score

24

Deep Value Investing Score

1

Defensive Investing Score

3

Dividend Investing Score

1.5

Economic Moat Investing Score

1.8

Garp Investing Score

1

Growth Investing Score

0.5

Momentum Investing Score

0.5

Net Net Investing Score

2

Quality Investing Score

1.5

Value Investing Score

3.5

Quarters > 0 > quarter

2025-06-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

1366524

Quarters > 0 > income Statement > operating Income

-1366524

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-1240415

Quarters > 0 > income Statement > net Income

-1240415

Quarters > 0 > income Statement > eps

-0.05

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

24808300

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-1366524

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

126109

Quarters > 0 > income Statement > currency_symbol

USD

Quarters > 0 > balance Sheet > cash

3189943

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

3393961

Quarters > 0 > balance Sheet > property Plant Equipment

99989

Quarters > 0 > balance Sheet > total Assets

4331302

Quarters > 0 > balance Sheet > payables

-

Quarters > 0 > balance Sheet > short Term Debt

43405

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

2556806

Quarters > 0 > balance Sheet > equity

1774496

Quarters > 0 > balance Sheet > currency_symbol

USD

Quarters > 0 > cash Flow > net Income

-1240415

Quarters > 0 > cash Flow > depreciation

-

Quarters > 0 > cash Flow > change In Working Capital

-

Quarters > 0 > cash Flow > cash From Operations

-

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

-

Quarters > 0 > cash Flow > net Change In Cash

-

Quarters > 0 > cash Flow > currency_symbol

USD

Quarters > 0 > ratios > PE

-0.05

Quarters > 0 > ratios > PB

65.5628435792473

Quarters > 0 > ratios > ROE

-69.90238355003336

Quarters > 0 > ratios > ROA

-28.638386332793235

Quarters > 0 > ratios > FCF

-

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

24

Quarters > 1 > quarter

2024-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

360180

Quarters > 1 > income Statement > operating Income

-360180

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-351936

Quarters > 1 > income Statement > net Income

-351936

Quarters > 1 > income Statement > eps

-

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

-

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-360180

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

8244

Quarters > 1 > income Statement > currency_symbol

USD

Quarters > 1 > balance Sheet > cash

-

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

-

Quarters > 1 > balance Sheet > property Plant Equipment

-

Quarters > 1 > balance Sheet > total Assets

-

Quarters > 1 > balance Sheet > payables

-

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

-

Quarters > 1 > balance Sheet > equity

-

Quarters > 1 > balance Sheet > currency_symbol

-

Quarters > 1 > cash Flow > net Income

-351936

Quarters > 1 > cash Flow > depreciation

-

Quarters > 1 > cash Flow > change In Working Capital

-

Quarters > 1 > cash Flow > cash From Operations

-

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

-

Quarters > 1 > cash Flow > net Change In Cash

-

Quarters > 1 > cash Flow > currency_symbol

USD

Quarters > 1 > ratios > PE

-

Quarters > 1 > ratios > PB

-

Quarters > 1 > ratios > ROE

-

Quarters > 1 > ratios > ROA

-

Quarters > 1 > ratios > FCF

-

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

45

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

0

Annuals > 0 > income Statement > cost Of Revenue

-

Annuals > 0 > income Statement > gross Profit

-

Annuals > 0 > income Statement > operating Expenses

1797124

Annuals > 0 > income Statement > operating Income

-1797124

Annuals > 0 > income Statement > interest Expense

-

Annuals > 0 > income Statement > pretax Income

-1768415

Annuals > 0 > income Statement > net Income

-1768415

Annuals > 0 > income Statement > eps

-

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

-

Annuals > 0 > income Statement > income Tax Expense

-

Annuals > 0 > income Statement > EBITDA

-1749641

Annuals > 0 > income Statement > operating Margin

-

Annuals > 0 > income Statement > total Other Income Expense Net

28709

Annuals > 0 > income Statement > currency_symbol

USD

Annuals > 0 > balance Sheet > cash

872599

Annuals > 0 > balance Sheet > short Term Investments

-

Annuals > 0 > balance Sheet > receivables

-

Annuals > 0 > balance Sheet > inventories

-

Annuals > 0 > balance Sheet > total Current Assets

1097924

Annuals > 0 > balance Sheet > property Plant Equipment

120452

Annuals > 0 > balance Sheet > total Assets

2048889

Annuals > 0 > balance Sheet > payables

-

Annuals > 0 > balance Sheet > short Term Debt

40660

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

2226321

Annuals > 0 > balance Sheet > equity

-177432

Annuals > 0 > balance Sheet > currency_symbol

USD

Annuals > 0 > cash Flow > net Income

-1768415

Annuals > 0 > cash Flow > depreciation

47483

Annuals > 0 > cash Flow > change In Working Capital

-1856

Annuals > 0 > cash Flow > cash From Operations

-1361305

Annuals > 0 > cash Flow > capital Expenditures

99475

Annuals > 0 > cash Flow > cash From Investing

-99475

Annuals > 0 > cash Flow > cash From Financing

1152382

Annuals > 0 > cash Flow > net Change In Cash

-308398

Annuals > 0 > cash Flow > currency_symbol

USD

Annuals > 0 > ratios > PE

-

Annuals > 0 > ratios > PB

-

Annuals > 0 > ratios > ROE

996.671964470896

Annuals > 0 > ratios > ROA

-86.31092265125149

Annuals > 0 > ratios > FCF

-1460780

Annuals > 0 > ratios > Piotroski FScore

0

Annuals > 0 > ratios > fcf Percent

-

Annuals > 0 > health Score

40

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

0

Annuals > 1 > income Statement > cost Of Revenue

-

Annuals > 1 > income Statement > gross Profit

-

Annuals > 1 > income Statement > operating Expenses

2308149

Annuals > 1 > income Statement > operating Income

-2308149

Annuals > 1 > income Statement > interest Expense

-

Annuals > 1 > income Statement > pretax Income

-2292267

Annuals > 1 > income Statement > net Income

-2292267

Annuals > 1 > income Statement > eps

-

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

-

Annuals > 1 > income Statement > income Tax Expense

-

Annuals > 1 > income Statement > EBITDA

-2264229

Annuals > 1 > income Statement > operating Margin

-

Annuals > 1 > income Statement > total Other Income Expense Net

15882

Annuals > 1 > income Statement > currency_symbol

USD

Annuals > 1 > balance Sheet > cash

1180997

Annuals > 1 > balance Sheet > short Term Investments

-

Annuals > 1 > balance Sheet > receivables

-

Annuals > 1 > balance Sheet > inventories

-

Annuals > 1 > balance Sheet > total Current Assets

1201817

Annuals > 1 > balance Sheet > property Plant Equipment

33222

Annuals > 1 > balance Sheet > total Assets

2013560

Annuals > 1 > balance Sheet > payables

-

Annuals > 1 > balance Sheet > short Term Debt

25156

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

1927792

Annuals > 1 > balance Sheet > equity

85768

Annuals > 1 > balance Sheet > currency_symbol

USD

Annuals > 1 > cash Flow > net Income

-2292267

Annuals > 1 > cash Flow > depreciation

43920

Annuals > 1 > cash Flow > change In Working Capital

229741

Annuals > 1 > cash Flow > cash From Operations

-1377680

Annuals > 1 > cash Flow > capital Expenditures

44306

Annuals > 1 > cash Flow > cash From Investing

-44306

Annuals > 1 > cash Flow > cash From Financing

500000

Annuals > 1 > cash Flow > net Change In Cash

-921986

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

-

Annuals > 1 > ratios > PB

-

Annuals > 1 > ratios > ROE

-2672.636647700774

Annuals > 1 > ratios > ROA

-113.84150459882001

Annuals > 1 > ratios > FCF

-1421986

Annuals > 1 > ratios > Piotroski FScore

0

Annuals > 1 > ratios > fcf Percent

-

Annuals > 1 > health Score

17

Valuation > metrics > PE

-0.05

Valuation > metrics > PB

65.5628435792473

Valuation > final Score

20

Valuation > verdict

2085.4% Overvalued

Profitability > metrics > ROE

-69.90238355003336

Profitability > metrics > ROA

-36.54770929895776

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

1.4408632084828594

Risk > metrics > Interest Coverage

-10.836054524260758

Risk > final Score

-13

Risk > verdict

High

Liquidity > metrics > Current Ratio

78.19285796567216

Liquidity > metrics > Quick Ratio

78.19285796567216

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

50

Prev Valuations > 1

0

Prev Valuations > 2

0

Prev Profitabilities > 0

50

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-145

Prev Risks > 1

0

Prev Risks > 2

0

Prev Liquidities > 0

50

Prev Liquidities > 1

0

Prev Liquidities > 2

0

Updated At

2026-01-20T22:44:13.448Z

Earnings History > 0 > period

2025-12-31

Earnings History > 0 > report Date

2026-03-26

Earnings History > 0 > date

2025-12-31

Earnings History > 0 > before After Market

BeforeMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

-

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-

Earnings History > 1 > period

2025-09-30

Earnings History > 1 > report Date

2025-11-13

Earnings History > 1 > date

2025-09-30

Earnings History > 1 > before After Market

-

Earnings History > 1 > currency

-

Earnings History > 1 > eps Actual

-0.07

Earnings History > 1 > eps Estimate

0

Earnings History > 1 > eps Difference

-0.07

Earnings History > 1 > surprise Percent

-

Earnings History > 2 > period

2025-06-30

Earnings History > 2 > report Date

2025-09-16

Earnings History > 2 > date

2025-06-30

Earnings History > 2 > before After Market

-

Earnings History > 2 > currency

-

Earnings History > 2 > eps Actual

-0.05

Earnings History > 2 > eps Estimate

0

Earnings History > 2 > eps Difference

-0.05

Earnings History > 2 > surprise Percent

-